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ABSTRACT
The cytotoxic effects of thiopurine drugs are
mostly exerted through the formation of thioguanine
nucleotide and its subsequent incorporation
into DNA. The 6-thioguanine (6-TG) in DNA can
be converted to S
6-methylthio-2-aminopurine (2-AP-
6-SCH3) and 2-aminopurine-6-sulfonic acid (2-AP-6-
SO3H) upon reaction with S-adenosyl-L-methionine
and irradiation with UVA light, respectively. Here we
prepared oligodeoxynucleotides (ODNs) harboring a
6-TG, 2-AP-6-SCH3 or 2-AP-6-SO3H at a defined site
and examined, by using LC-MS/MS, the in vitro
replication of these substrates with yeast polymer-
ase g and Klenow fragment (KF
 ). Our results
revealed that 2-AP-6-SCH3 could be bypassed by
KF
 , with significant misincorporation of thymine
opposite the lesion. The 2-AP-6-SO3H, however,
blocked markedly the nucleotide insertion by KF
 .
Yeast pol g could bypass all three modified nucleo-
sides; although dCMP was inserted preferentially,
we found substantial misincorporation of dTMP and
dAMP opposite 2-AP-6-SCH3 and 2-AP-6-SO3H,
respectively. Moreover, both KF
  and yeast pol g
induced a considerable amount of -2 frameshift
products from the replication of 2-AP-6-SCH3- and
2-AP-6-SO3H-bearing substrates. Our results also
underscored the importance of measuring the
relative ionization efficiencies of replication pro-
ducts in the accurate quantification of these pro-
ducts by LC-MS/MS. Moreover, thermodynamic
studies revealed that 2-AP-6-SCH3 and 2-AP-6-
SO3H could cause more destabilization to duplex
DNA than 6-TG. Taken together, the results from this
study shed important new light on the bio-
logical implications of the two metabolites of 6-TG.
Abbreviations: 6-thioguanine, 6-TG; thioguanine
nucleotide (TGN); oligodeoxynucleotide, ODN;
S
6-methylthio-2-aminopurine, 2-AP-6-SCH3; 2-ami-
nopurine-6-sulfonic acid, 2-AP-6-SO3H; S-adenosyl-
L-methionine, S-AdoMet; 1,1,1,3,3,3-hexafluoro-2-
propanol, HFIP; electrospray ionization, ESI; 30-50-
Exonuclease-free Klenow fragment, KF
–; uracil-DNA
glycosylase, UDG; polyacrylamide gel electrophor-
esis, PAGE; melting temperature, Tm.
INTRODUCTION
Thiopurine drugs, 6-thioguanine (6-TG), 6-mercaptopu-
rine and its prodrug azathioprine, are common therapeu-
tic agents for the treatment of acute leukemia,
inﬂammatory bowl disease, autoimmune hepatitis and
other pathological conditions (1–4). The primary activa-
tion pathway of the thiopurine drugs is through the
formation of thioguanine nucleotide (TGN) and its
subsequent incorporation into DNA (1,5). Although
extensive studies on 6-TG metabolism have been carried
out (2,6), the biochemical mechanisms for its cytotoxicity
remain largely unclear, partially because of the lack of a
strong mutagenic eﬀect of 6-TG (7,8). On the other hand,
further transformation of 6-TG in DNA might be
involved in the cytotoxicity of the thiopurine drugs.
In this regard, 6-TG in DNA can be methylated
by S-adenosyl-L-methionine (S-AdoMet) to give
S
6-methylthio-2-aminopurine (2-AP-6-SCH3, Scheme 1)
(9). In addition, 6-TG in DNA can be oxidized to
2-aminopurine-6-sulfonic acid (2-AP-6-SO3H, Scheme 1)
upon UVA irradiation (10–12).
Both metabolites of 6-TG may miscode during DNA
replication (9,10,12). In this respect, it was found that
2-AP-6-SCH3 could block slightly the replication by 30-50-
Exonuclease-free Klenow fragment (KF
 ) (9), and, while
the primer extension experiments were carried out in the
presence of dCTP or dTTP alone, the insertion of dTMP
*To whom correspondence should be addressed. Tel: 909-787-2700; Fax: 909-787-4713; Email: yinsheng.wang@ucr.edu
 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.opposite the lesion by KF
  was found to be nearly as
eﬃcient as the incorporation of dCMP (9). In addition,
2-AP-6-SO3H can be bypassed by a Y-family DNA
polymerase, human pol Z (10); on the other hand,
a very recent study revealed that this lesion blocked
DNA synthesis by KF
  (12).
The NMR structural data and thermodynamic studies
suggested that the replacement of a guanine with a 6-TG
perturbs slightly the normal helical form of DNA (13–16),
where the sulfur atom in 6-TG exists in keto form and
assumes weakened Watson–Crick hydrogen bonding
with the opposing cytosine. However, the other two
important metabolites of 6-TG, namely, 2-AP-6-SCH3
and 2-AP-6-SO3H, have not been investigated thoroughly
for their eﬀects on duplex stability.
We set out to examine, in detail, how the two modiﬁed
thionucleobases aﬀect DNA replication and duplex
stability by using structurally deﬁned substrates. In this
context, the steady-state kinetics assay has been com-
monly used for determining the cytotoxic and mutagenic
properties of DNA lesions in vitro (17). In these
experiments, the eﬃciency and ﬁdelity of nucleotide
incorporation are determined by measuring the rates for
the incorporation of one type of nucleotide at a time
and ﬁtting the rate data with the Michaelis–Menten
equation (17). Recently, Guengerich et al. (18,19)
introduced an elegant LC-MS/MS method to investigate
the multiple bypass mechanisms of polymerases
toward DNA lesions in vitro. This method provides an
eﬃcient way for determining the identities and distribu-
tions of various replication products resulting from
the polymerase reaction in the presence of all four
dNTPs, which, relative to the conditions used for
steady-state kinetic measurements, mimics better the
replication conditions in vivo.
The previous LC-MS/MS quantiﬁcation of replication
products was based on the relative ion abundances of the
composing oligodeoxynucleotides (ODNs) observed in
ESI-MS under an assumption that diﬀerent ODNs,
regardless of their lengths and nucleobase compositions,
have the same ionization eﬃciency (18,19). This assump-
tion, however, may not be valid owing to the fact that the
hydrophobicity and free energy of solvation for diﬀerent
ODNs can vary, which can aﬀect their signal intensities
in ESI mass spectrum (20). Thus, accurate LC-MS/MS
quantiﬁcation of the replication products requires the
consideration of the diﬀerent ionization eﬃciencies for
diﬀerent ODNs.
In the present study, we prepared ODNs containing a
6-TG, 2-AP-6-SCH3 or 2-AP-6-SO3H at a deﬁned site and
carried out the in vitro replication studies by using an
improved LC-MS/MS method, which takes into account
the ionization eﬃciency diﬀerences of ODNs. We also
measured the thermodynamic parameters for the forma-
tion of duplexes bearing a 6-TG and its oxidized/
methylated derivatives. The results from this study
provide insights toward understanding the biological
implications of 6-TG and its major metabolites.
MATERIALS AND METHODS
Chemicals and enzymes
The phosphoramidite building block of 6-thio-20-deoxy-
guanosine was obtained from Glen Research (Sterling,
VA, USA). Unmodiﬁed ODNs used in this study were
purchased from Integrated DNA Technologies
(Coralville, IA, USA). [g-
32P]ATP was obtained from
Amersham Biosciences Co. (Piscataway, NJ, USA).
All other chemicals unless otherwise noted were obtained
from Sigma-Aldrich (St Louis, MO, USA). 30-50-
Exonuclease-free KF
  and uracil-DNA glycosylase
(UDG) were from New England Biolabs (Ipswich, WA,
USA). The C-terminal catalytic core of yeast
Saccharomyces cerevisiae pol Z, which was an
N-terminally His6-tagged fusion protein (21), was kindly
provided by Prof. John-Stephen A. Taylor at Washington
University in St Louis.
Preparation of ODN substratescontaining a6-thioguanine
or its metabolites
We ﬁrst synthesized 6-TG-bearing ODNs by using
phosphoramidite chemistry. After solid-phase synthesis,
the controlled pore-glass (CPG) support was treated
with 1.0M DBU (1,8-Diazabicyclo[5.4.0]undec-7-ene) in
anhydrous acetonitrile at room temperature for 5h to
remove the cyanoethyl protecting group for the thionu-
cleoside, followed by treatment with 50mM NaSH in
O
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Scheme 1. The formation of 2-AP-6-SCH3 and 2-AP-6-SO3H.
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for 24h to complete the deprotection. The synthesized
d(ATGGC
SGCGCTAT) (‘
SG’ represents 6-TG) was
puriﬁed by HPLC and its identity was conﬁrmed by
ESI-MS and tandem MS (MS/MS).
The 2-AP-6-SCH3-containing substrates were prepared
following previously published procedures (22). Brieﬂy,
d(ATGGC
SGCGCTAT) (20nmol) was treated with 10%
CH3I/CH3CN (v/v) in 0.05M phosphate buﬀer (pH 8.5)
at room temperature overnight, and the methylation
reaction was quenched by addition of HCl until the
solution pH reached 7.0. The reaction mixture was
separated by HPLC on a 4.6 250mm Apollo C18
reverse-phase column (5mm in particle size and 300A ˚ in
pore size, Alltech Associates Inc., Deerﬁeld, IL, USA).
The composition of buﬀer A was 50mM TEAA (pH 6.5),
and buﬀer B contained 50mM TEAA and 30% acetoni-
trile (v/v). The gradient program for the mobile phase was:
0min, 0% B; 5min, 20% B; 45min, 50% B; 50min, 100%
B; 55min, 0% B. The ﬂow rate was 0.8ml/min, and a UV
detector was set at 260nm to monitor the eﬄuents.
The identity of the methylated ODN
d(ATGGC
MeSGCGCTAT) (‘
MeSG’ designates 2-AP-6-
SCH3) was conﬁrmed by ESI-MS and MS/MS.
Selective oxidation of 6-TG in ODNs was performed
according to previously published procedures for the
oxidation of 2-AP-6-SCH3-bearing ODNs (22). In this
respect, d(ATGGC
SGCGCTAT) (50 nmol) was incu-
bated with 50-ml of 3.56mM magnesium monoperox-
yphthalate (MMPP) at room temperature for 1h.
The oxidation mixture was separated by HPLC with the
conditions described above. The identity and purity of
2-AP-6-SO3H -containing ODN were conﬁrmed by ESI-
MS and the sequence of the ODN was veriﬁed by MS/MS.
The presence of 2-AP-6-SO3H in the resulting ODN was
also supported by its characteristic ﬂuorescence spectrum.
To further conﬁrm the structure of the oxidation
product of 6-TG, the 2-AP-6-SO3H-containing dodecamer
(1nmol) was digested by four enzymes, i.e. nuclease P1,
calf spleen phosphodiesterase, snake venom phosphodies-
terase and alkaline phosphatase, to give mononucleosides
(23,24). The nucleoside mixture was separated by using a
0.5 150mm Zorbax SB-C18 column (particle size, 5 mm,
Agilent Technologies, Palo Alto, CA, USA). The HPLC
gradient was 0–15% acetonitrile in 20mM ammonium
acetate in 60min, and the ﬂow rate was 6.0ml/min, which
was delivered by using an Agilent 1100 capillary HPLC
pump (Agilent Technologies).
The eﬄuent from the LC column was coupled directly
to an LTQ Linear ion-trap mass spectrometer (Thermo
Electro Inc., San Jose, CA, USA). The spray voltage was
4.0kV, and the capillary temperature was maintained at
2258C. The mass spectrometer was set up to monitor the
fragmentation of the [M–H]
  ion (m/z 330) of 2-AP-6-
SO3H2 0-deoxyribonucleoside, i.e. d(2-AP-6-SO3H).
Standard d(2-AP-6-SO3H) was also injected in a separate
LC-MS/MS experiment with the identical experimental
setup as that for the digestion sample.
For the modiﬁed ODNs used in replication studies,
a 20-mer ODN, d(ATGGC
SGCGCTATGATCCTAG),
was ﬁrst synthesized. This ODN was then selectively
methylated or oxidized by using the same experimental
protocols as described above for the dodecameric
substrates.
Primerextension assays by gelelectrophoresis
For primer extension assays, the 20-mer lesion-containing
or unmodiﬁed ODN (20nM) was annealed with a 50-
32P-
labeled 15-mer primer, d(GCTAGGATCATAGCG)
(10nM) and the resulting ODN solution was incubated
with 100mM of each of the four dNTPs and a DNA
polymerase (KF
  or yeast pol Z) in a buﬀer containing
10mM Tris–HCl (pH 7.5), 5mM MgCl2 and 7.5mM
DTT. The reactions were continued at 378C for 60min
and then quenched by adding a 2-volume excess of
formamide gel-loading buﬀer [80% formamide, 10mM
EDTA (pH 8.0), 1mg/ml xylene cyanol and 1mg/ml
bromophenol blue]. The replication products were
resolved on 20% (1:19) cross-linked denaturing polyacryl-
amide gels containing 8M urea. Gel images were obtained
by using a Typhoon 9410 Variable Mode Imager
(Amersham Biosciences Co.).
Primerextension assays by LC-MS/MS
We replaced the primer used in gel electrophoresis with an
unlabeled, uracil-containing ODN, d(GCTAGGATCAU
AGCG), which facilitated the production, after UDG
treatment, of short ODNs containing the extended portion
of the primer (Scheme 2). These short ODNs were readily
amenable to sequencing analysis by MS/MS (18). The
lesion-containing template and primer (100 pmol each)
were annealed and incubated at 378C in the presence of
1mM dNTPs and a buﬀer containing 10mM Tris–HCl
(pH 7.5), 5mM MgCl2 and 7.5mM DTT. KF
  (2 U) or
yeast pol Z (1.6mg) was added and the reaction was
continued overnight. The replication reaction was stopped
X: 6-TG, 2-AP-6-SCH3, or 2-AP-6-SO3H
N: random nucleobases inserted 
5′- ATG GCX CGC TAT GAT CCT AG –3′
3’- GCG AUA CTA GGA TCG –5′
KF−/yeast pol η, 4 dNTPs
5′- ATG GCX CGC TAT GAT CCT AG – 3′
3′- NN NNN NNN GCG AUA CTA GGA TCG – 5′ 
UDG hydrolysis
d(pA GCG NNN NNN NN)– 3′
5′- ATG GCX CGC TAT GAT CCT AG – 3′
d(GCT AGG ATC Ap)– 3′
ATG GC CGC TAT GAT CCT AG 
3’- GCG AUA CTA GGA TCG 
ATG GC CGC TAT GAT CCT AG 
NN NNN NNN GCG AUA CTA GGA TCG 
UDG hydrolysis
5′- d(pA GCG NNN NNN NN)–
ATG GCX CGC TAT GAT CCT AG 
5′- d(GCT AGG ATC Ap)–
LC-MS/MS
Scheme 2. Experimental procedures for the LC-MS/MS analysis of
replication products.
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was then incubated with UDG (4 U) in a buﬀer contain-
ing 20mM Tris–HCl (pH 8.0), 1mM DTT and 1mM
EDTA at 378C for 5h. The UDG cleavage reaction
was quenched by adding piperidine until its ﬁnal
concentration reached 0.25M. The resulting mixture was
then incubated at 608C for 1h, the proteins in the mixtures
were removed by chloroform extraction, and the aqueous
layer was dried by using a Savant Speed-Vac (Thermo
Savant Inc., Holbrook, NY, USA). The dried residue was
redissolved in 100-mlH 2O for the following LC-MS/MS
analysis (A 25-ml aliquot was injected in each run).
The conditions for LC-MS/MS analysis were similar as
described above. The gradient for the HPLC elution was
as follows: 0–5min, 0–20% methanol in 400mM
1,1,1,3,3,3-hexaﬂuoro-2-propanol (HFIP, pH was
adjusted to 7.0 by addition of triethylamine); 5–40min,
20–50% methanol in 400mM HFIP. The capillary
temperature was maintained at 3008C to minimize the
formation of the HFIP adducts of ODNs. MS/MS data
were acquired over an m/z range of 500–1500.
To identify the replication products, the mass spectro-
meter was ﬁrst operated in data-dependent scan mode,
where the four most abundant ions found in MS were
chosen for fragmentation in MS/MS. The MS/MS data
were then manually inspected to assign the fragment ions
and determine the sequences of the ODNs. In this respect,
some tandem mass spectra were not of high-enough
quality for complete sequence assignments. These spectra
were recorded again by monitoring speciﬁcally the
fragmentation of the precursor ions. After identifying
the ODNs from the replication mixture, the quantiﬁcation
of replication products was carried out by operating the
instrument in speciﬁc-ion monitoring mode, where the
precursor ions for the extended fragments of the primer
strand were chosen for fragmentation. The speciﬁc-ion
monitoring mode oﬀered enhanced signal-to-noise ratio
for the measurement of replication products.
To correct for the eﬀect of varied ionization eﬃciencies
of diﬀerent ODNs on quantiﬁcation, we introduced a
relative-ratio method. To this end, we ﬁrst obtained the
standard phosphorylated ODNs by treating 20nmol
unphosphorylated ODNs with 20 U of T4 polynucleotide
kinase (New England Biolabs) in a buﬀer containing
50mM Tris–HCl (pH 7.5), 10mM MgCl2, 1mM ATP,
10mM DTT and 25mg/ml BSA at 378C for 1h.
Immediately after the reaction, the reaction mixture was
extracted with chloroform to remove the enzymes.
The aqueous layer was dried, redissolved in water, and
subjected to HPLC separation, where the gradient
program was 0–40% methanol in 50mM phosphate
buﬀer (pH 6.8) in 60min. The phosphate buﬀer, instead
of TEAA buﬀer, was employed to avoid the loss of
terminal phosphate group from the 50-phosphorylated
ODNs.
A mixture composed of 5pmol each of the standard
phosphorylated ODN substrates, which were identiﬁed in
each set of replication mixture (shown in Tables 1 and 2),
was dispersed in the same buﬀer as that used in the
extension assays and injected for LC-MS and MS/MS
analyses with the same experimental setup as that used
for the analysis of the replication mixture. The integrated
area of peak, which was found in the total-ion chromato-
gram (TIC) plotted for the production of the most
abundant deprotonated molecular ion for each standard
ODN, or in the selected-ion chromatogram (SIC) plotted
for the formation of three abundant fragment ions of
the ODN, was normalized against that of one speciﬁc
ODN. The corresponding normalized ratios for the
replication samples were also determined and combined
with the ratios obtained from the analyses of standards
to calculate the percentage of each product in the
replication mixture.
Here we use the KF
 -mediated reaction of the 2-AP-6-
SO3H-bearing substrate as an example to illustrate how
the method works. In this reaction mixture, we found
Table 1. Percentages of the replication products in the reaction with Klenow fragment
Name Sequence 6-TG 2-AP-6-SCH3 2-AP-6-SO3H
4mer d(pAGCG) 2.9 0.4 8.4 0.6 32 4
5C d(pAGCGC) 0.7 0.0 1.6 0.7 21.4 0.9
5T d(pAGCGT) 0.2 0.0 1.1 0.0 4.5 0.0
5A d(pAGCGA) 0.6 0.0 2.4 0.1 6.0 0.7
6C d(pAGCGCC) ND ND 14 2
8C d(pAGCGCCAT) ND 4.8 0.3 5.5 0.2
11C d(pAGCGCGCCATA) 19.3 0.2 12.6 0.8 17 2
11T d(pAGCGTGCCATA) 3.2 0.0 35 2N D
11A d(pAGCGAGCCATA) 1.5 0.0 0.9 0.0 0.8 0.0
11G d(pAGCGGGCCATA) ND 5.2 0.4 ND
12C d(pAGCGCGCCATAT) 45 7 6.7 0.0 ND
12T d(pAGCGTGCCATAT) 4.2 0.5 18 1N D
12A d(pAGCGAGCCATAT) 12 2 3.7 0.0 ND
13C d(pAGCGCGCCATATA) 8.2 0.1 0.4 0.0 ND
13T d(pAGCGTGCCATATA) 0.5 0.0 ND ND
13A d(pAGCGAGCCATATA) 1.3 0.0 ND ND
The template is d(ATGGCXCGCTATGATCCTAG), where ‘X’ represents 6-TG, 2-AP-6-SCH3 or 2-AP-SO3H. For all the full-length products,
the nucleosides incorporated opposite the lesion are highlighted in bold.
ND, not detectable.
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substrates are listed in Table 1. To determine the
percentage of the un-extended primer (4mer) in the
reaction mixture, we ﬁrst determined the ratio of
the peak area for the 4mer over that for the 11C found
in the SICs for the analysis of the mixture of standard
ODNs, i.e. R8 (4mer) (the SICs are shown in Figure S8):
R ð4merÞ¼
A ð4merÞ
A ð11CÞ
:
We then calculated the corresponding ratio for the
analysis of the replication mixture:
Rð4merÞ¼
Að4merÞ
Að11CÞ
:
The A8 and A represented the peak areas found in SICs
for the analysis of standards and replication samples,
respectively. The ratio determined for the replication
mixture was then normalized against that determined for
the standards, which gave normalized ratio for the 4-mer,
i.e. RR(4mer):
RR 4mer ðÞ ¼
R 4mer ðÞ
R0 4mer ðÞ
:
The normalized ratio was then calculated for each
identiﬁed replication product, and the percentage of 4mer
in the replication mixture was calculated from the ratio of
the normalized ratio for the 4mer over the sum of the
normalized ratios for all the replication products by using
the following equation:
Pð4merÞ¼
RRð4merÞ
RRð4merÞþRRð5CÞþRRð5TÞþRRð5AÞ
þRRð6CÞþRRð8CÞþRRð11CÞþRRð11AÞ

:
Other replication products present in this or other
polymerase-catalyzed reaction mixtures were calculated in
the same fashion.
Measurementof melting curves
The above dodecameric ODNs containing a guanine,
6-TG or its modiﬁed derivative were annealed with
another 12-mer ODN to form the duplex. The speciﬁc
nucleotide sequences were:
Strand 1 50- ATGGCXCGCTAT -30
Strand 2 30- TACCGCGCGATA -50,
where ‘X’ represents an unmodiﬁed guanine, 6-TG, or
its methylated/oxidized derivative.
The UV absorbance-versus-temperature proﬁles were
recorded on a Varian Cary 500 spectrophotometer
(Varian Inc., Palo Alto, CA, USA), and the ODNs were
dispersed in a 1.2-ml solution containing 10mM phos-
phate (pH 7.0), 100mM NaCl and 0.1mM EDTA at a
varying total ODN concentration (Ct) of 1.0, 1.8, 3.2, 5.6,
or 10mM. The absorbance was recorded in the reverse and
forward directions for a temperature range of 80–108Ca t
a rate of 18C/min, and the melting temperature (Tm) value
was obtained by the derivative method (25).
The thermodynamic parameters were obtained from the
van’t Hoﬀ plot (25), where the reciprocal of Tm was
plotted against ln Ct/4:
1
Tm
¼
R
H 

ln
Ct
4
þ
S 
H 
and
G  ¼ H    TS 
in which R is the universal gas constant (¼1.987 cal
mol
 1 K
 1). The error limits for iG8, iH8 and iS8
Table 2. Percentages of the replication products in the reaction with yeast pol Z
Name Sequences 6-TG 2-AP-6-SCH3 2-AP-6-SO3H
4mer d(pAGCG) 11 21 8  22 2  2
5C d(pAGCGC) 0.4 0.0 ND 1.3 0.0
5A d(pAGCGA) ND ND 0.2 0.0
5G d(pAGCGG) ND ND 0.2 0.0
6C d(pAGCGCC) 0.4 0.0 ND 2.7 0.0
6A d(pAGCGAC) ND ND 0.6 0.0
6G d(pAGCGGC) 1.3 0.3 ND 0.3 0.0
8C d(pAGCGCCAT) 4.1 0.7 5.0 0.3 29 3
8A d(pAGCGACAT) ND ND 6.9 0.7
10C d(pAGCGCGCCAT) 39 63 9  92 0  2
10T d(pAGCGTGCCAT) 3.4 0.6 13 3N D
10A d(pAGCGAGCCAT) 1.8 0.3 5 1 4.0 0.4
10G d(pAGCGGGCCAT) ND ND 0.7 0.0
11C d(pAGCGCGCCATA) 8.6 0.5 3.7 0.8 1.6 0.0
11T d(pAGCGTGCCATA) 1.0 0.0 1.4 0.0 0.8 0.0
11A d(pAGCGAGCCATA) 0.5 0.0 ND ND
11C_T d(pAGCGCGCCATT) 26 4 9.3 0.2 6.9 0.6
11T_T d(pAGCGTGCCATT) 0.8 0.0 2.6 0.0 0.4 0.0
11A_T d(pAGCGAGCCATT) 2.4 0.4 3.0 0.7 1.8 0.1
The template is d(ATGGCXCGCTATGATCCTAG), where ‘X’ represents 6-TG, 2-AP-6-SCH3 or 2-AP-SO3H. For all the full-length products,
the nucleosides incorporated opposite the lesion are highlighted in bold.
ND, not detectable.
Nucleic Acids Research, 2007, Vol. 35, No. 11 3697derived from ﬁtted parameters were calculated by using
previously the described equations (26).
RESULTS
Preparation ofODNs containing a6-thioguanine or its
modification products
We employed traditional phosphoramidite chemistry and
synthesized two 6-TG-containing ODNs, d(ATGGC
S
GCGCTAT) and d(ATGGC
SGCGCTATGATCCTAG).
The identities of these two substrates were conﬁrmed by
ESI-MS and MS/MS analyses (Figures S1 and S4).
As reported previously (22), 6-TG in ODNs can be
selectively methylated to 2-AP-6-SCH3 by treatment with
methyl iodide (CH3I) in a phosphate buﬀer (pH 8.5,
Scheme 1). In addition, 2-AP-6-SCH3 in ODNs can be
oxidized selectively to 2-AP-6-SO2CH3 upon treatment
with MMPP (magnesium monoperoxyphthalate) (22).
We employed similar procedures and isolated the desired
2-AP-6-SCH3- and 2-AP-6-SO3H-containing ODNs from
the reaction mixtures by HPLC (Scheme 1 and Figure S2).
The yields for the selective formation of these two
products, as estimated from peak areas in the HPLC
traces, were  45 and 75%, respectively (Figure S2).
The molecular masses of the 2-AP-6-SCH3- and 2-AP-6-
SO3H-containing dodecameric ODNs were measured by
ESI-MS to be 3690.9 and 3724.8Da, respectively, which
are in accordance with the corresponding calculated
average masses of 3691.3 and 3725.0Da, respectively.
Moreover, the sites of the lesions were conﬁrmed by the
product-ion spectra (MS/MS) of the [M–3H]
3  ions of
these ODNs (Figure 1).
The 2-AP-6-SO3H-containing substrate was further
examined by ﬂuorescence spectroscopy and LC-MS/MS
analysis of the enzyme-generated nucleosides of the ODN
(see Materials and Methods). The oxidized ODN gave
identical ﬂuorescence spectrum (Figure S3) as the authen-
tic d(2-AP-6-SO3H), which had an excitation maximum at
324nm and an emission maximum at 410nm (10).
LC-MS/MS of the nucleoside mixture showed a fraction
eluting at the same time ( 8min) and exhibiting the same
MS/MS fragmentation pattern as the standard d(2-AP-6-
SO3H) (data not shown).
The same methylation and oxidation procedures were
employed to obtain the 20-mer ODNs containing the two
metabolites of 6-TG. The identities of the 20-mer
substrates were again conﬁrmed by ESI-MS and MS/MS
(Figure S4).
In-vitro replication studies with KF
  and yeast polgby gel
electrophoresis
We next examined how the presence of 6-TG or its
oxidized/methylated derivative aﬀects DNA replication by
carrying out primer extension assays with a replicative
polymerase, KF
  and a Y-family DNA polymerase, yeast
pol Z. As depicted in Figure S5, 6-TG and 2-AP-6-SCH3
inhibited slightly the replication by KF
 , whereas the
presence of a 2-AP-6-SO3H inhibited KF
 -mediated
DNA replication to a greater extent. The latter result
was consistent with what was reported by Zhang and
coworkers (12). Yeast pol Z, on the other hand, could
bypass 6-TG and its modiﬁed derivatives to give full-
length products.
LC-MS/MS analysis of in-vitro replication products
We further assessed the bypass and miscoding properties
of 6-TG and its metabolites by LC-MS/MS following the
previously described method (18,19) with some modiﬁca-
tions. In this context, we adopted the HFIP buﬀer system,
which was ﬁrst reported by Hancock et al. (27) for the
LC-ESI-MS/MS analysis of ODNs. It turned out that this
buﬀer system resulted in high eﬃciency in both HPLC
separation and electrospray ionization of ODNs with
minimal cation adduction.
To illustrate this, we use the analysis of the yeast pol Z-
catalyzed primer extension products of the 2-AP-6-SCH3-
containing substrate as an example. As shown in the
TIC (Figure 2a), the lesion-bearing strand elutes at
29.5min. After UDG cleavage and hot alkaline treatment,
the 50 portion of the primer is produced in two forms,
namely, d(GCTAGGATCAp) and d(GCTAG
GATCAXp) (‘X’ represents an abasic site), eluting at
26.5min and 26.0min, respectively. The latter form results
from the incomplete cleavage of the abasic site by hot
piperidine treatment, which might be attributed to the
relatively low temperature (i.e. 608C) employed for the
treatment. The 30 portion of the primer strand, which
carried the extension products and included 10C, 10T,
10A, 11C, 11T, 11C_T, 11T_T, 11A_T, elutes at 26.9min
(ESI-MS averaged from this retention time is shown in
Figure 2b, and the sequences for the identiﬁed products
are listed in Table 2). Other than these full-length
products, we also found the un-extended primer (4mer)
and a frame-shift product (8C), which elute at 20.8min
and 26.5min, respectively. The identities of the above
ODNs were determined from ESI-MS and MS/MS
measurements. For instance, the MS/MS of several
replication products, including a frameshift product,
are shown in Figure S7, and the MS/MS for the
[M–4H]
4  ions of the 50 segments of the primer are
shown in Figure S6. The same LC-MS/MS method also
allows us to identify the replication products from the
other ﬁve in vitro replication reactions (the identiﬁed
products are listed in Tables 1 and 2).
To quantify accurately the relative amounts of these
extension products, we ﬁrst examined the relative ioniza-
tion eﬃciencies of ODNs in negative-ion ESI-MS. To this
end, we injected a mixture, which contained 5-pmol of
each standard 50-phosphorylated ODN in the same
buﬀer as that used for extension assays, for LC-MS and
MS/MS analyses. As depicted in Figure 3, the seventeen
50-phosphorylated ODNs identiﬁed from the pol
Z-mediated replication mixture of the 2-AP-6-SO3H-
bearing substrate indeed exhibit substantially diﬀerent
eﬃciencies in forming the most abundant molecular ions,
revealing the importance of considering the varied
ionization eﬃciencies of diﬀerent ODNs in the LC-MS/
MS quantiﬁcation of replication products. In this respect,
the relative ionization eﬃciencies were assessed by
normalizing the total-ion current observed for the most
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Figure 1. Product-ion spectra of the ESI-produced [M–3H]
3  ions of d(ATGGC
SO3HGCGCTAT) (m/z 1240.6, a) and d(ATGGC
MeSGCGCTAT)
(m/z 1229.3, b), where ‘
SO3HG’ and ‘
MeSG’ represent 2-AP-6-SO3H and 2-AP-6-SCH3, respectively. Shown in the insets are the negative-ion ESI-MS
for the two modiﬁed ODNs and schemes summarizing the observed fragment ions.
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Figure 2. (a) Total-ion chromatogram from the analysis of the yeast pol Z-induced replication products that have been treated with UDG and hot
piperidine. A 25-pmol replication mixture was injected for analysis. (b) ESI-MS averaged from the peak eluting at 26.9 min in part (a), where ‘*p’
designates the remanent of the 50 portion of the primer.
3700 Nucleic Acids Research, 2007, Vol. 35, No. 11abundant deprotonated molecular ion found for each
ODN against that found for the [M–3H]
3  ions of 10C,
for the yeast pol Z-mediated reaction, and 11C, for the
KF
 -catalyzed reaction (See Figure S8 for an example).
In the viewpoint that MS/MS provides improved signal-
to-noise ratio for measuring the relative amounts of
diﬀerent ODNs present in the replication mixture, we also
examined the relative eﬃciencies for the formation of
three abundant fragment ions, from the injection of an
equimolar mixture (5pmol each) of the 17 authentic
ODNs as mentioned earlier. It turned out that the ratios
obtained for most ODNs are similar to those found based
on molecular ions, and the eﬃciencies for the formation of
three abundant product ions were again markedly
diﬀerent for these ODNs (Figure 3). In this respect,
t-test showed that, at 99.9% conﬁdence level, the mean
ratio obtained for 10A or 10G was signiﬁcantly diﬀerent
from that determined for 4mer, 5C, 5G, 6C, 6A, 6G, 8A,
10A, 11C or 11T_T.
It is worth noting that two isomeric ODN products
were found in the pol Z-catalyzed replication mixture of
all three thionucleoside-containing substrates (Table 2 and
Figure S10), i.e. 11T or 11A_T, which exhibit very similar
retention time. Therefore, the quantiﬁcation of these two
products has to rely on MS/MS. In this context, it is worth
noting that the quantiﬁcation of these two ODNs also
necessitates the use of fragment ions with distinct m/z
values for the two ODNs. In this case, we employed the
[a6-G]
2 ,[ a 7-C]
2  and [a8-C]
2  ions, which have m/z
values of 870.6, 1035.1 and 1179.7, respectively, for 11T
and 875.1, 1039.7 and 1184.1, respectively, for 11A_T
[Nomenclature for fragment ions follows that described by
McLuckey et al. (28)].
By using the relative ratio method described in
‘Materials and Methods’ section, we quantiﬁed the
percentages of individual ODNs in the reaction mixtures
and summarized the results in Tables 1 and 2. Our results
showed that KF
  could bypass 6-TG eﬃciently, and the
most abundant product was found to be the products with
a dCMP being inserted opposite the 6-TG and with
the blunt-end addition of a dA, d(AT) or d(ATA) (Table 1
and Figure S9d). Consistent with the results from the
primer extension monitored by PAGE analysis, the 2-AP-
6-SCH3-containing substrate can also be bypassed; how-
ever, the 2-AP-6-SCH3 induced much more nucleotide
misincorporation than 6-TG. Among all the full-length
products, dTMP ( 53%) is inserted opposite the 2-AP-6-
SCH3 much more preferentially than dCMP ( 20%),
followed by dAMP ( 5%) and dGMP ( 5%, Table 1 and
Figure S9e). This result is signiﬁcantly diﬀerent from the
similar eﬃciency of dCMP and dTMP incorporation in
primer extension experiments where only dTTP or dCTP
was present in the replication mixture (9).
The 2-AP-6-SO3H-bearing substrate blocked KF
 -
mediated primer extension more readily as represented
by the formation of much smaller amount of the full-
length products (a total of  18%, Table 1 and Figure S8).
In contrast to what we found for the 2-AP-6-SCH3-
containing substrate, KF
  preferentially incorporates a
dCMP opposite 2-AP-6-SO3H. Considering the full-length
products formed from this reaction, the incorporation of
dCMP and dAMP constitute 17% (11C, Table 1) and
0.8% (11A, Table 1), respectively, whereas the insertion of
dTMP was barely detectable.
For the primer extension with yeast pol Z, substrates
containing 6-TG and its metabolites can all be bypassed
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Figure 3. Ratios of peak areas of individual ODNs to that of 10C in the mixture based on the SIC (solid bar), and based on TIC (open bar).
All authentic ODNs were identiﬁed from the replication mixture of 2-AP-6-SO3H-containing substrates induced by yeast pol Z. Error bars represent
the standard deviations of results from three independent experiments. The top and bottom numbers listed above the bars are data obtained from
SICs for three abundant fragment ions and based on TICs for the most abundant molecular ion, respectively.
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the results obtained from the above gel electrophoresis
experiment. For all three lesions, the most abundant
products carry the correct nucleotide (dCMP) opposite the
lesion (Table 2, the SICs for monitoring the formation of
replication products and a summary of the identities and
percentages of those products are shown in Figure S9).
Aside from the correct nucleotide incorporation, the
insertions of dAMP and dTMP were also observed
(Table 2). In this respect, if we only consider the full-
length products, dCMP, dTMP and dAMP were inserted
opposite 6-TG at frequencies of 74, 5.2 and 4.7%,
respectively (Table 2), whereas these three nucleotides
were incorporated opposite 2-AP-6-SCH3 at frequencies
of 52, 17 and 8%, respectively (Table 2). The respective
frequencies for the insertion of these three nucleotides
opposite 2-AP-6-SO3H are 29, 1.2 and 5.8%. These
results, therefore, demonstrated that 2-AP-6-SO3H
also blocked pol Z-mediated polymerization more
eﬀectively than 6-TG or 2-AP-6-SCH3 (Table 2).
In keeping with our ﬁndings for the KF
 -mediated
reaction, pol Z also misincorporated dTMP more
frequently than dAMP opposite 2-AP-6-SCH3, whereas
the wrong nucleotide dAMP was inserted opposite the
2-AP-6-SO3H with greater eﬃciency than the incorrect
nucleotide dTMP.
It is worth mentioning that a single LC-MS/MS
experiment facilitates us to gain insights into both the
nucleotide incorporation opposite the lesion and the
primer extension beyond the lesion site. In this
context, our data demonstrated the presence of a
signiﬁcant amount of frame-shift products in the
reaction mixture, particularly in the mixtures resulting
from the replication of 2-AP-6-SO3H-harboring
substrate induced by yeast pol Z (6C, 6A, 6G, 8C and
8A, a total of  40%, Figure S9c) and KF
  (6C and 8C,
a total of  20%, Figure S8).
Thermodynamic properties of lesion-containing duplexes
To gain insights into the eﬀects of 6-TG and its
metabolites on duplex stability, we further determined
the thermodynamic parameters for duplex formation by
measuring the melting temperatures for the thionucleo-
side-containing duplex ODNs (see ‘Materials and
Methods’ section and Figure S10). It turned out that the
replacement of a guanine with a 6-TG resulted in the
destabilization of the duplex by 2.4kcal/mol in free
energy at 378C (Table 3). In addition, 2-AP-6-SCH3 and
2-AP-6-SO3H caused even more destabilization to duplex
DNA, with iiG being 4.2 and 4.3kcal/mol, respectively
(Table 3).
DISCUSSION
The cytotoxicity of the thiopurine drugs involved mostly
the formation of 6-TG nucleotide upon metabolic activa-
tion and its subsequent incorporation into DNA (2).
In DNA, 6-TG can be methylated by S-AdoMet to form
2-AP-6-SCH3 (9) and converted to 2-AP-6-SO3H upon
UVA irradiation (10). Both 2-AP-6-SCH3 and 2-AP-6-
SO3H may aﬀect DNA replication and/or repair,
thereby exerting their cytotoxic and mutagenic eﬀects
in vivo (9,10).
In this article, we obtained pure ODNs containing a
structurally deﬁned 6-TG, 2-AP-6-SCH3, or 2-AP-6-SO3H
at a speciﬁc site, and conﬁrmed the identities of these
ODNs by ESI-MS, MS/MS and, for the 2-AP-6-SO3H-
bearing substrate, by ﬂuorescence spectroscopy. In addi-
tion, the 2-AP-6-SO3H-containing ODN was digested by
enzymes to mononucleosides, and LC-MS/MS analysis
conﬁrmed the presence of 2-AP-6-SO3H2 0-deoxyribonu-
cleoside in the nucleoside mixture.
We then carried out the in vitro replication studies of
6-TG and its metabolites with KF
  and yeast pol Z.
Consistent with previous studies (9,29), we found that
6-TG and 2-AP-6-SCH3 slightly blocked the replication by
KF
 , whereas 2-AP-6-SO3H blocked substantially the
primer extension by KF
 . All three thionucleosides,
however, could be bypassed by yeast pol Z with varying
eﬃciencies.
The miscoding and polymerase stalling properties of
DNA lesions are frequently assessed by the steady-state
kinetics assay (17). Recently, LC-MS/MS, because of its
high eﬃciency and its capability in oﬀering sequence
information for many ODNs in a single experiment,
has been developed as a new tool to investigate the
mutagenic and cytotoxic eﬀects of DNA lesions
in vitro (18). Diﬀerent from the steady-state assay, the
LC-MS/MS method can allow for the analysis of the
replication products from the reactions with the mutual
presence of all four dNTPs, instead of adding one type of
dNTP at a time. It may better represent the real
polymerization reaction conditions in vivo, thereby pro-
viding more accurate measurements. However, the
Table 3. Thermodynamic parameters of duplex formation
Duplex Ta
mð
 CÞ DH (kcal/mol) DS (cal/mol K) DG378C (kcal/mol) DDG
b
37 C
50-ATGGCXCGCTAT-30
30-TACCGCGCGATA-50
X¼G 60.9 0.5  80 5  210 16  13.8 0.3
X¼6-TG 51.2 0.6  77 4  210 14  11.4 0.2 2.4 0.4
X¼2-AP-6-SCH3 43.8 0.5  74.1 0.6  208 2  9.6 0.0 4.2 0.3
X¼2-AP-6-SO3H 43.8 0.5  82 2  230 8  9.5 0.0 4.3 0.3
aCt ¼10mM.
bDDG
b
37 C ¼ DG37 C (lesion-containing duplex)—DG378C (undamaged duplex).
3702 Nucleic Acids Research, 2007, Vol. 35, No. 11LC-MS/MS analysis of extended ODNs in the replication
mixture was somewhat limited because common HPLC
mobile phases are not compatible with both the HPLC
separation and the electrospray ionization of ODNs.
Here we found that the HFIP buﬀer reported by
Hancock et al. (27) allowed for the eﬀective separation
and eﬃcient ionization of ODNs in the replication
reaction mixture.
In this newly developed LC-MS/MS method, the
quantitative analysis of individual ODNs in the reaction
mixture is complicated by the diﬀerent ionization eﬃcien-
cies of the composing ODNs. In this article, we
quantitatively assessed the ionization and detection
eﬃciencies of diﬀerent ODNs through the analysis of
authentic compounds. Our results revealed that diﬀerent
ODNs could exhibit signiﬁcant diﬀerences in the magni-
tude of signals produced in MS or MS/MS, which calls for
the need of assessing the relative ionization eﬃciencies
of diﬀerent ODNs while LC-MS/MS is used for this type
of analysis.
With the consideration of diﬀerent ionization eﬃcien-
cies of diﬀerent replication products, our LC-MS/MS
results revealed that dTMP is inserted opposite 2-AP-6-
SCH3 with much greater eﬃciency (2.5-fold) than dCMP
by KF
 . The resulting 2-AP-6-SCH3/T base pair may
trigger the DNA mismatch repair pathway (9). If not
repaired eﬃciently, the lesion may lead to a high incidence
of G!A transversion mutation. Our LC-MS/MS
data also demonstrated that 2-AP-6-SO3H can block
signiﬁcantly the extension by KF
  as represented by the
formation of a large amount of the unextended primer
(4mer, 32%, Figure S8) and pentameric products (5C, 5A
and 5T, larger than 30% in total, Figure S8), suggesting
that this lesion may introduce signiﬁcant structure
distortion to duplex DNA. However, the translesion
synthesis polymerase, yeast pol Z, can bypass all
three thionucleosides, including 2-AP-6-SO3H, and give
full-length products. Although dCMP is the most
favorite nucleotide being inserted opposite 2-AP-6-SCH3
and 2-AP-6-SO3H, we observed signiﬁcant frequencies
of misincorporation of dTMP and dAMP opposite 2-AP-
6-SCH3 and 2-AP-6-SO3H, respectively.
Other than nucleotide misincorporation opposite
the lesion sites, we also found a substantial amount of -2
frameshift products in the replication mixtures for 2-AP-6-
SCH3- and 2-AP-6-SO3H-containing substrates.
Remarkably, this type of products account for  40% of
the products in the pol Z-mediated replication of the
2-AP-6-SO3H-containing substrate. We reason that three
possible mechanisms may contribute to the formation of
these products (Scheme 3). In this respect, yeast pol Z
incorporates both dCMP and dAMP opposite the lesion,
and the resulting 2-AP-6-SO3H/A and the 2-AP-6-SO3H/
C base pairs may distort the local double helix structure,
which may cause the two bases on the 50 side of the lesion
to ﬂip out. The polymerase can then continue to add one
or three correct nucleotides in the presence of template
(Scheme 3, left). Other two mechanisms involve the
looping-out of the lesion together with ﬂanking 30 or 50
nucleotide followed by the incorporation of the
correct nucleotides by the polymerase (Scheme 3, middle
and right). The latter two mechanisms may account for
the high occurrences of 6C and 8C in the replication
mixtures of 2-AP-6-SO3H-containing substrate mediated
by KF
  or pol Z. In this context, it is worth noting that
diﬀerent ﬂanking sequences may give rise to diﬀerent types
of frameshift products.
The thermodynamic studies revealed that the presence
of a 6-TG caused an increase in iG8 at 378C by 2.4kcal/
mol relative to that of the parent duplex. The iiG8 was
close to that induced by one mismatched base pair (30).
The presence of 2-AP-6-SCH3 and 2-AP-6-SO3H resulted
in even greater destabilization to duplex DNA, i.e. by 4.2–
4.3kcal/mol in Gibbs free energy at 378C. The increased
destabilization to double-stranded DNA induced by 2-
AP-6-SCH3 and 2-AP-6-SO3H than by 6-TG may facil-
itate the more eﬃcient recognition of the two lesions by
DNA repair enzymes, though other factors, e.g. substrate
speciﬁcities of DNA repair enzymes and base pairing, may
also contribute to the recognition of these lesions during
repair (31,32).
Since the approval of the thiopurine drugs by FDA in
the 1960s, azathioprine, 6-mercaptopurine, and 6-TG have
been widely used as therapeutic agents in the treatment of
a variety of human diseases (1,3). However, there is a high
occurrence of certain cancers in long-term survivors of
these patients (33–35). For example, 20 years after
transplant, about 60–90% of the patients who have
taken azathioprine as an immunosuppressant develop
squamous cell carcinoma (36). Such great prevalence of
skin cancer in transplant patients is not found in the
general population. The methylation and oxidation of
6-TG, due to the increased potential in miscoding and in
inducing frameshift mutations, may contribute to the
development of cancers in those patients. In this respect, it
was shown that aberrant processing of 2-AP-6-SCH3/T
mismatch was more toxic in mismatch repair-proﬁcient
than in deﬁcient cells (32). Future studies on the
quantiﬁcation of these lesions formed in vivo and in vivo
mutagenesis study of these lesions using shuttle vector
technology should oﬀer more insights into the roles of
these lesions in the development of cancers in those
patients who have been treated with the thiopurine drugs.
Such studies are currently being pursued in our
laboratory.
5′ -AGCG– 3′ 
CX GTA– 5’
CG
5′ -AGCGC/A/G– 3′
5′ -AGCGC  C– 3′
3′ -TCGCX GTA– 5′
CG
5′ -AGCGC  CAT– 3′
3′-TCGCX GTA–
CG
5′
XC
3′ -TCGC  GGTA–
XC
5′ -AGCG  CC– 3′
XC
5′-AGCG  CCAT– 3′
3′ -TCG  CGGTA– 5′
CX
5′ -AGC  G– 3′
3′ -TCG  CGGTA– 5′
CX
5′ -AGC  GCC– 3′
3′ -TCG  CGGTA– 5′
CX
5′ -AGC  GCCAT– 3′
3′ -TCGCXCGGTA– 5′ 
3′ -TCGCX GTA– 5’
CG
CX GTA–
CG
CX GTA– 5′
CG
3′-TCGC  GGTA–
XC
5′-AGCG– 3′
5′
XC
3′-TCGC  GGTA– 5′
XC
CX
CX
CX
Scheme 3. Proposed mechanisms for the formation of  2 frameshift
mutation products.
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